CME Funding Not Reportable Under Sunshine Law, But Bias Debate Continues
ACCME report finds “no evidence to support or refute” belief that commercial support creates commercial bias in CME activities.
You may also be interested in...
CMS releases data on $3.5 billion worth of payments made by drug and device companies to physicians and teaching hospitals in the last five months of 2013; an additional 199,000 payment records were not disclosed.
Accreditation Council for Continuing Medical Education reports that commercial support for CME activities declined in 2011 but the number of activities increased 3.8%; more than 20 million participated in CME programs.
CBER director Peter Marks says the FDA may evaluate giving gene therapy products the ‘degree of responsiveness’ that COVID-19 vaccines received. In a discussion of the pandemic's effects on staff retention, CDER director Patrizia Cavazzoni says attrition rates are back to historical levels.